| Nov 18 |
Ginkgo Bioworks: Unproven Transition But 2025 Is Looking Better
|
| Nov 15 |
Ginkgo Bioworks Holdings Third Quarter 2024 Earnings: Beats Expectations
|
| Nov 13 |
Ginkgo Bioworks: Not Enough Progress
|
| Nov 13 |
Ginkgo Bioworks Holdings, Inc. (DNA) Q3 2024 Earnings Call Transcript
|
| Nov 12 |
Ginkgo Bioworks surges 14% as it ups 2024 revenue forecast
|
| Nov 12 |
Ginkgo Bioworks Holdings GAAP EPS of -$1.08 beats by $2.24, revenue of $89.05M beats by $44.06M
|
| Nov 12 |
Ginkgo Bioworks Reports Third Quarter 2024 Financial Results
|
| Nov 12 |
Ginkgo Bioworks completes first milestone in Merck collaboration
|
| Nov 12 |
Ginkgo Bioworks Advances Collaboration with Merck to Improve Biologics Manufacturing
|
| Nov 12 |
Earnings Scheduled For November 12, 2024
|
